2024 |
Bristol-Myers Squibb Co.
|
Lead Independent Director |
440 K |
3.5 % |
2024 |
Centene Corp.
|
Independent Director |
350.0 K |
-0.0 % |
2024 |
Iron Mountain Inc.
|
Independent Director |
- |
- |
2023 |
Bristol-Myers Squibb Co.
|
Lead Independent Director |
425 K |
0.0 % |
2023 |
Centene Corp.
|
Independent Director |
350.0 K |
-50.8 % |
2023 |
Iron Mountain Inc.
|
Independent Director |
190.4 K |
- |
2023 |
Perrigo Company plc
|
Independent Director |
32.8 K |
-91.7 % |
2022 |
Centene Corp.
|
Independent Director |
711.2 K |
- |
2022 |
Bristol-Myers Squibb Co.
|
Lead Independent Director |
425 K |
9.1 % |
2022 |
Perrigo Company plc
|
Independent Director |
395.5 K |
0.0 % |
2021 |
Perrigo Company plc
|
Independent Director |
395.5 K |
-0.0 % |
2021 |
Bristol-Myers Squibb Co.
|
Lead Independent Director |
389.6 K |
11.3 % |
2021 |
Centene Corp.
|
Independent Director |
- |
- |
2020 |
Perrigo Company plc
|
Independent Director |
395.5 K |
1.7 % |
2020 |
Bristol-Myers Squibb Co.
|
Independent Director |
350 K |
3.7 % |
2019 |
Perrigo Company plc
|
Independent Director |
389.0 K |
0.4 % |
2019 |
Bristol-Myers Squibb Co.
|
Independent Director |
337.5 K |
9.8 % |
2018 |
Perrigo Company plc
|
Independent Director |
387.5 K |
-12.7 % |
2018 |
Bristol-Myers Squibb Co.
|
Independent Director |
307.5 K |
5.7 % |
2017 |
Perrigo Company plc
|
Independent Director |
443.8 K |
- |
2017 |
Bristol-Myers Squibb Co.
|
Independent Director |
291.0 K |
- |
2016 |
Perrigo Company plc
|
Independent Director |
- |
- |